Exelixis to Release Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
Exelixis (Nasdaq: EXEL) has announced the release date for its third quarter 2024 financial results. The results will be disclosed on Tuesday, October 29, 2024, after the markets close. Following the release, Exelixis management will host a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results and provide a general business update.
Interested parties can access the event via the Internet from the company's website. To join the conference call, registration is required through a provided link, which will supply a dial-in number and unique PIN. The live webcast can be accessed through the Event Calendar page under the Investors & News section of www.exelixis.com. A replay of the webcast will be archived on the company's website for one year.
Exelixis (Nasdaq: EXEL) ha annunciato la data di pubblicazione dei risultati finanziari del terzo trimestre 2024. I risultati saranno comunicati martedì 29 ottobre 2024, dopo la chiusura dei mercati. Successivamente alla pubblicazione, la direzione di Exelixis terrà una call e un webcast alle 17:00 ET / 14:00 PT per discutere i risultati e fornire un aggiornamento generale sull'azienda.
Le parti interessate possono accedere all'evento tramite Internet dal sito web dell'azienda. Per partecipare alla conference call è necessaria una registrazione tramite un link fornito, che fornirà un numero di accesso e un PIN unico. Il webcast in diretta sarà accessibile tramite la pagina del Calendario Eventi nella sezione Investitori & News di www.exelixis.com. Una registrazione del webcast sarà archiviata sul sito dell'azienda per un anno.
Exelixis (Nasdaq: EXEL) ha anunciado la fecha de lanzamiento de sus resultados financieros del tercer trimestre de 2024. Los resultados se revelarán el martes 29 de octubre de 2024, después del cierre de los mercados. Después del anuncio, la dirección de Exelixis llevará a cabo una videoconferencia y transmisión en vivo a las 5:00 p.m. ET / 2:00 p.m. PT para discutir los resultados y proporcionar una actualización general del negocio.
Las partes interesadas pueden acceder al evento a través de Internet desde el sitio web de la empresa. Para unirse a la llamada, es necesario registrarse a través de un enlace proporcionado, que proporcionará un número de acceso y un PIN único. La transmisión en vivo se puede acceder a través de la página del Calendario de Eventos en la sección de Inversores y Noticias de www.exelixis.com. Una repetición de la transmisión se archivará en el sitio web de la empresa durante un año.
엑셀릭스 (Nasdaq: EXEL)는 2024년 3분기 재무 결과 발표 날짜를 발표했습니다. 결과는 2024년 10월 29일 화요일에 시장 종료 후 공개됩니다. 발표 후 엑셀릭스 경영진은 컨퍼런스 콜 및 웹캐스트를 오후 5시 ET / 오후 2시 PT에 개최하여 결과를 논의하고 비즈니스 전반에 대한 업데이트를 제공합니다.
관심 있는 분들은 회사 웹사이트를 통해 인터넷으로 행사에 접근할 수 있습니다. 컨퍼런스 콜에 참여하려면 제공된 링크를 통해 등록해야 하며, 이 링크는 다이얼인 번호와 고유한 PIN을 제공합니다. 생중계 웹캐스트는 www.exelixis.com의 투자자 및 뉴스 섹션 아래 이벤트 캘린더 페이지를 통해 접근할 수 있습니다. 웹캐스트의 재생은 회사 웹사이트에 1년 동안 보관됩니다.
Exelixis (Nasdaq: EXEL) a annoncé la date de publication de ses résultats financiers du troisième trimestre 2024. Les résultats seront révélés le mardi 29 octobre 2024, après la fermeture des marchés. Suite à la publication, la direction d'Exelixis animera une conférence téléphonique et un webinaire à 17h00 ET / 14h00 PT pour discuter des résultats et donner une mise à jour générale sur l'entreprise.
Les parties intéressées peuvent accéder à l'événement via Internet depuis le site de l'entreprise. Pour rejoindre la conférence téléphonique, une inscription est requise via un lien fourni, qui fournira un numéro d'appel et un code PIN unique. Le webinaire en direct peut être consulté sur la page Calendrier des événements dans la section Investisseurs & Actualités de www.exelixis.com. Un replay du webinaire sera archivé sur le site de l'entreprise pendant un an.
Exelixis (Nasdaq: EXEL) hat das Veröffentlichungsdatum für die finanziellen Ergebnisse des dritten Quartals 2024 bekannt gegeben. Die Ergebnisse werden am Dienstag, den 29. Oktober 2024, nach Börsenschluss veröffentlicht. Nach der Bekanntgabe wird das Management von Exelixis eine Telefonkonferenz und einen Webcast um 17:00 Uhr ET / 14:00 Uhr PT abhalten, um die Ergebnisse zu diskutieren und eine allgemeine Geschäftsinformation zu geben.
Interessierte Parteien können über die Website des Unternehmens auf die Veranstaltung zugreifen. Um an der Telefonkonferenz teilzunehmen, ist eine Registrierung über einen bereitgestellten Link erforderlich, der eine Telefonnummer und eine eindeutige PIN zur Verfügung stellt. Der Live-Webcast kann über die Seite des Veranstaltungskalenders im Abschnitt Investoren & Nachrichten von www.exelixis.com aufgerufen werden. Eine Wiederholung des Webcasts wird ein Jahr lang auf der Website des Unternehmens archiviert.
- None.
- None.
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT –
To access the conference call, please register using this link. Upon registration, a dial-in number and unique PIN will be provided to join the call. To access the live webcast link, log onto www.exelixis.com and proceed to the Event Calendar page under the Investors & News heading. A webcast replay of the conference call will also be archived on www.exelixis.com for one year.
About Exelixis
Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care. Powered by drug discovery and development excellence, we are rapidly evolving our product portfolio to target an expanding range of tumor types and indications with our clinically differentiated pipeline of small molecules, antibody-drug conjugates and other biotherapeutics. This comprehensive approach harnesses decades of robust investment in our science and partnerships to advance our investigational programs and extend the impact of our flagship commercial product, CABOMETYX® (cabozantinib). Exelixis is driven by a bold scientific pursuit to create transformational treatments that give more patients hope for the future. For information about the company and its mission to help cancer patients recover stronger and live longer, visit www.exelixis.com, follow @ExelixisInc on X (Twitter), like Exelixis, Inc. on Facebook and follow Exelixis on LinkedIn.
Exelixis, the Exelixis logo and CABOMETYX are registered
View source version on businesswire.com: https://www.businesswire.com/news/home/20241015906059/en/
Investors Contact:
Varant Shirvanian
Director, Investor Relations
Exelixis, Inc.
650-837-7917
vshirvanian@exelixis.com
Media Contact:
Hal Mackins
For Exelixis, Inc.
415-994-0040
hal@torchcommunications.com
Source: Exelixis, Inc.
FAQ
When will Exelixis (EXEL) release its Q3 2024 financial results?
What time is the Exelixis (EXEL) Q3 2024 earnings conference call?
How can I access the Exelixis (EXEL) Q3 2024 earnings call?
Where can I find the webcast for Exelixis (EXEL) Q3 2024 earnings?
